<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue journalpublishing.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1</article-id><article-id pub-id-type="publisher-id">2009MOLVIS0356</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>An association study of <italic>SERPING1</italic> gene and age-related macular degeneration in a Han Chinese population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Fang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Peiquan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fan</surname><given-names>Yinchuan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Shibo</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Jianbin</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xiaoqi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Xian</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yiye</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lei</surname><given-names>Chuntao</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Jiyun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Shi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Chunyong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yang</surname><given-names>Zhenglin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Center for Human Molecular Biology &#x00026; Genetics, Sichuan Academy of Medical Sciences &#x00026; Sichuan Provincial People&#x02019;s Hospital, Sichuan, China</aff><aff id="aff2"><label>2</label>Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University, Shanghai, China</aff><aff id="aff3"><label>3</label>Department of Ophthalmology, Sichuan Academy of Medical Sciences &#x00026; Sichuan Provincial People&#x02019;s Hospital, Sichuan, China</aff><aff id="aff4"><label>4</label>Zhongshan Ophthalmic Center, Guangdong, China</aff><aff id="aff5"><label>5</label>Department of Ophthalmology, School of Medicine, Qingdao University, Qingdao, China</aff></contrib-group><author-notes><fn><p>The first four authors contributed equally to this work.</p></fn><corresp id="cor1">Correspondence to: Dr. Zhenglin Yang, Center for Human Molecular Biology &#x00026; Genetics, Sichuan Academy of Medical Sciences &#x00026; Sichuan Provincial People&#x02019;s Hospital, 32 The First Round Road 2 West, Chengdu, Sichuan, China; Phone: 86-28-87393548; Fax: 86-28-87393596; email: <email xlink:href="zliny@yahoo.com">zliny@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>10</day><month>1</month><year>2010</year></pub-date><volume>16</volume><fpage>1</fpage><lpage>6</lpage><history><date date-type="received"><day>13</day><month>10</month><year>2009</year></date><date date-type="accepted"><day>06</day><month>1</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2010 Molecular Vision.</copyright-statement><copyright-year>2010</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>Single nucleotide polymorphisms (SNPs) in the complement component 1 inhibitor (<italic>SERPING1</italic>) gene have been shown to be significantly associated with age-related macular degeneration (AMD) in Caucasian populations. A replication study of an association between these SNPs and AMD in a Chinese population is reported in this study.</p></sec><sec><title>Methods</title><p>Six SNPs, including <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511990">rs2511990</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1005510">rs1005510</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs11546660">rs11546660</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511989">rs2511989</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511988">rs2511988</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs4926">rs4926</ext-link> in <italic>SERPING1</italic> were genotyped in a Han Chinese subject group using the SNaPshot method of ABI. This subject group was composed of 194 patients with choroidal neovascularization (CNV or wet) AMD, 78 patients with soft drusen, and 285 matched controls. P values of the SNPs were calculated using an additive model. Haplotype frequencies between cases and controls were compared by &#x003c7;2 analysis. The haplotype analysis was performed using Haploview 4.0.</p></sec><sec><title>Results</title><p>None of the six SNPs showed significant association with AMD. None of the major haplotypes were observed to be significantly associated with AMD or choroidal neovascularization AMD (CNV) after a stringent Bonferroni correction.</p></sec><sec><title>Conclusions</title><p>We demonstrate that SNPs in <italic>SERPING1</italic> are not significantly associated with AMD in the mainland Han Chinese population.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Yang</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly population, characterized as chronic and progressive degeneration of photoreceptors, the underlying retinal pigment epithelium (RPE), Bruch&#x02019;s membrane, and possibly, the choriocapillaris in the macula [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r2">2</xref>]. AMD is divided clinically into dry and wet AMD. Patients with dry AMD present with cellular debris (drusen) in or under the retinal pigment epithelium (RPE), irregularities in the pigmentation of the RPE, or geographic atrophy (GA). Patients with exudative or wet AMD are characterized by serous detachment of the RPE or choroidal neovascularization (CNV), or both [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r2">2</xref>]. Advanced AMD, including geographic atrophy or exudative disease, can cause severe vision loss.</p><p>It is believed that AMD is a complex disorder caused by the interaction of multiple genetic and environmental risk factors [<xref ref-type="bibr" rid="r3">3</xref>&#x02013;<xref ref-type="bibr" rid="r7">7</xref>]. Identification of AMD related genes has been tremendously successful. Complement pathway genes, including complement factor <italic>H</italic> (<italic>CFH</italic>) [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r8">8</xref>&#x02013;<xref ref-type="bibr" rid="r13">13</xref>], <italic>C2/CFB</italic> [<xref ref-type="bibr" rid="r14">14</xref>&#x02013;<xref ref-type="bibr" rid="r16">16</xref>], and <italic>C3</italic> [<xref ref-type="bibr" rid="r15">15</xref>&#x02013;<xref ref-type="bibr" rid="r17">17</xref>], have been confirmed by many replication studies. The <italic>LOC387715/HTRA1</italic> gene has also been verified as a major AMD locus in different populations [<xref ref-type="bibr" rid="r18">18</xref>&#x02013;<xref ref-type="bibr" rid="r24">24</xref>]. Recently, SNPs in the serpin peptidase inhibitor, clade G (C1 inhibitor) member 1 (<italic>SERPING1</italic>) gene showed highly significant genotypic association with age-related macular degeneration in two Caucasian populations [<xref ref-type="bibr" rid="r25">25</xref>]. Unfortunately, this finding could not be replicated by other studies [<xref ref-type="bibr" rid="r26">26</xref>&#x02013;<xref ref-type="bibr" rid="r34">34</xref>].</p><p>To further analyze the association of <italic>SERPING1</italic> and AMD, we investigated the association between SNPs in this gene and AMD in a mainland Han Chinese population.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>The Institutional Review Boards of the Sichuan Provincial People&#x02019;s Hospital, Xinhua Hospital of Shanghai Jiao Tong University, and Zhongshan Ophthalmic Center, China approved this study. All subjects provided informed consent before participation in the study. AMD patients and normal age-matched controls, including individuals with a normal eye examination (individuals age 60 years or older with no drusen or RPE changes), were recruited in the ophthalmology clinic at Sichuan Provincial People&#x02019;s Hospital, Xinhua Hospital of Shanghai Jiao Tong University, and Zhongshan Ophthalmic Center, China. All participants went through a standard examination protocol as in the previous description [<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r27">27</xref>]. Grading was performed using a standard grid classification suggested by the International ARM Epidemiological Study Group for age-related maculopathy (ARM) and the age-related macular degeneration group [<xref ref-type="bibr" rid="r27">27</xref>]. All abnormalities in the macula were characterized according to the type, size and number of drusen, and hyperpigmentation or hypopigmentation, as well as AMD stages as defined by AREDS 1&#x02013;5 stages. Patients with clinical features of AMD and CNV (CNV from other causes was excluded), with or without drusen, were diagnosed as wet AMD patients. Patients with only soft drusen were diagnosed as drusen (dry AMD) patients. In total, 194 wet AMD patients (Eight from Zhongshan Ophthalmic Center, 28 from Xinhua Hospital, 158 from of the Sichuan Provincial People&#x02019;s Hospital), 78 soft drusen patients (all from of the Sichuan Provincial People&#x02019;s Hospital), and 285 normal matched controls (Eight from Zhongshan Ophthalmic Center, 30 from Xinhua Hospital and 247 from of the Sichuan Provincial People&#x02019;s Hospital) were recruited. In the normal matched controls, all individuals underwent an eye exam, no signs of early AMD, such as soft drusen or irregular pigmentations of the RPE in the macular area, were observed. Clinical information about the cases and controls is listed in <xref ref-type="table" rid="t1">Table 1</xref>.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Characteristics of amd cases and controls matched for ages and ethnicity.</title></caption><table frame="hsides" rules="groups"><col width="124" span="1"/><col width="81" span="1"/><col width="78" span="1"/><col width="80" span="1"/><col width="82" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Subject</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Total number</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Male</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Female</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Average age</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">All AMD (CNV+drusen)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">272<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">126<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">146<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">68.2&#x000b1;9.8<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">CNV<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">194<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">90<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">104<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">69.4&#x000b1;12.2<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">78<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">42<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">68.7&#x000b1;8.7<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Controls</td><td valign="top" align="center" rowspan="1" colspan="1">285</td><td valign="top" align="center" rowspan="1" colspan="1">132</td><td valign="top" align="center" rowspan="1" colspan="1">153</td><td valign="top" align="center" rowspan="1" colspan="1">68.4&#x000b1;7.2</td></tr></tbody></table></table-wrap></sec><sec><title>Selection of tag and functional SNPs</title><p>We used the data of the Han Chinese Beijing population in <ext-link ext-link-type="uri" xlink:href="http://hapmap.ncbi.nlm.nih.gov/">HapMap3</ext-link> of the international HapMap project and previous studies to select tag SNPs or functional SNPs in <italic>SERPING1</italic> [<xref ref-type="bibr" rid="r26">26</xref>,<xref ref-type="bibr" rid="r28">28</xref>] for this study. Six SNPs were selected for genotyping, including <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511990">rs2511990</ext-link> upstream of the transcription start site (&#x02212;2877 bases), <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1005510">rs1005510</ext-link> in intron 2, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs11546660">rs11546660</ext-link> (A56V) in exon 3, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511989">rs2511989</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511988">rs2511988</ext-link> in intron 6, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs4926">rs4926</ext-link> (M480V) in exon 8.</p></sec><sec><title>Genotyping</title><p>Blood from each subject was drawn and collected in an EDTA-containing tube. Genomic DNA was extracted from the blood by a Gentra Puregene Blood DNA kit (Minneapolis, MN). SNP genotyping was performed by the dye terminator-based SNaPshot method (Applied Biosystems, Foster City, CA). SNP analysis was performed on the ABI 3130 genetic analyzer (Applied Biosystems). Genotypes of the SNPs were determined by Genemapper software (Applied Biosystems). All SNPs reported in this manuscript had a genotyping success rate &#x0003e;96 percent and accuracy as judged by random re-genotyping of 10 percent of the samples in the subject group. Six SNPs in <italic>SERPING1</italic> were genotyped. The PCR and SNaPshot primers are listed in <xref ref-type="table" rid="t2">Table 2</xref>.</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Genotyping primers.</title></caption><table frame="hsides" rules="groups"><col width="63" span="1"/><col width="202" span="1"/><col width="399" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>PCR Primer Forward</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Snapshot Primer</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511989">rs2511989</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: TTCACAGCCTACCTTTCC<hr/></td><td rowspan="2" valign="top" align="left" colspan="1">CCCTGGGTTTAATACAGGGGTTGTCAACTC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R: CAGCCTCAATCATAATACCA<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511990">rs2511990</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: AAGCTGGAGCTGAAACTG<hr/></td><td rowspan="2" valign="top" align="left" colspan="1">GTTCTCTTCCCACTGGGAGCAGGTCTAGGATTTCTC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R: GGAAGAGGGATTCTGTGG<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1005510">rs1005510</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: TTCTTACTACGAGGCACA<hr/></td><td rowspan="2" valign="top" align="left" colspan="1">ATGTGGAAAATGTCCTGTACAAGAGAGTAATTTCTGACAGTGC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R: TAAATCAAGGAGCACAAG<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2244169">rs2244169</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: TGGCGTGAACCCTGGAGA<hr/></td><td rowspan="2" valign="top" align="left" colspan="1">CAGCCAGAAAAGTTTTACAAAGCACGTATATGAC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R: AGGTGGGAGGATTGCTTG<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511988">rs2511988</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F: AGTGGGCTGGAACTTGGA<hr/></td><td rowspan="2" valign="top" align="left" colspan="1">ATTGTGGGAGAGCTGCAGCTGCCCCACCTAGAAAATAAGAGATGCA</td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="left" rowspan="1" colspan="1">R: GCATTGTGACAGAGGGTG</td></tr></tbody></table></table-wrap></sec><sec><title>Haplotype analysis</title><p>Haplotype analysis was performed using <ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/haploview/haploview">Haploview 4.0</ext-link>. We performed the haplotype analysis following the instructions from the <ext-link ext-link-type="uri" xlink:href="http://www.broadinstitute.org/mpg/haploview">Broad Institute</ext-link>. If the genotype was not available, the genotype was set as 0.</p></sec><sec><title>Statistical analysis</title><p>Hardy&#x02013;Weinberg equilibrium (HWE) for each SNP polymorphism was tested by the &#x003c7;<sup>2</sup> test with df=1. P values of the SNPs were calculated using an additive model. Haplotype frequencies between cases and controls were compared by &#x003c7;<sup>2</sup> analysis. The unadjusted odds ratios of the alleles and genotypes were estimated by the &#x003c7;<sup>2</sup> test. All statistical analyses were performed using the software SPSS, (SPSS, Chicago, IL) version 10.0 [<xref ref-type="bibr" rid="r18">18</xref>&#x02013;<xref ref-type="bibr" rid="r24">24</xref>].</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Single nucleotide polymorphism analysis</title><p>All six SNPs selected were successfully genotyped and all of these SNPs were within HWE in both case (p&#x0003e;0.001, <xref ref-type="table" rid="t3">Table 3</xref>) and control groups (p&#x0003e;0.05, <xref ref-type="table" rid="t3">Table 3</xref>). The SNP frequencies in this study were similar to those of Han Chinese Beijing (HCB) available in HapMap3 in the International <ext-link ext-link-type="uri" xlink:href="http://hapmap.jst.go.jp/">HapMap</ext-link> Project. None of the six SNPs showed significant association with AMD or subphenotypes of AMD including wet AMD or soft drusen, which are landmarks of early AMD even before a stringent Bonferroni correction (p&#x02265;0.05, <xref ref-type="table" rid="t3">Table 3</xref>). SNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511989">rs2511989</ext-link> was reported to be the most significant association of SNP in the <italic>SERPING1</italic> gene with AMD in previous studies [<xref ref-type="bibr" rid="r25">25</xref>]. Although <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511989">rs2511989</ext-link> showed high polymorphism, no association between this SNP and AMD was observed in the Chinese population (p=0.76 for all AMD; p=0.61 for CNV AMD; p=0.77 for soft drusen).</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Association between subphenotypes of AMD ANS SNPS in <italic>SERPING1</italic> in the Han Chinese subject group.</title></caption><table frame="hsides" rules="groups"><col width="91" span="1"/><col width="111" span="1"/><col width="77" span="1"/><col width="49" span="1"/><col width="49" span="1"/><col width="43" span="1"/><col width="62" span="1"/><col width="40" span="1"/><col width="49" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP (risk allele)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Physical location (Chr.11)*</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Phenotype</bold></th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Genotype count</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Allele frequency</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>HWE</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Trend p-value</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511990">rs2511990</ext-link>&#x02028; (T)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57119284<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CVN+Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:211<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.003<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.59<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CNV<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:148<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:35<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.14<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.002<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.643<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.47<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Control<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:226<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:51<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.068<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs1005510">rs1005510</ext-link>&#x02028; (G)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57123798<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CVN+Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:140<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:117<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.27<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.135<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.44<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CNV<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:101<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:81<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.27<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.724<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.49<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:39<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:36<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.27<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.312<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.58<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Control<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:134<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:131<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:16<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.29<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.087<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs11546660">rs11546660</ext-link>&#x02028; (C)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57124043<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CVN+Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:249<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:21<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.506<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.05<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CNV<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:178<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:16<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.836<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:71<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.957<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.13<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Control<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:245<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:35<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.07<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.978<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511989">rs2511989</ext-link>&#x02028; (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57134901<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CVN+Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:198<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.706<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.76<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CNV<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:147<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:42<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.644<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.61<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:51<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:15<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.08<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.298<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.77<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Control<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:215<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.791<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511988">rs2511988</ext-link>&#x02028; (C)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57135746<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CVN+Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:155<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:103<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:14<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.25<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.557<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.99<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CNV<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:110<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:73<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.24<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.971<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.89<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:45<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:30<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.23<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.763<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.77<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Control<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TT:155<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CT:118<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CC:9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.24<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.025<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs4926">rs4926</ext-link>&#x02028; (A)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57138565<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CVN+Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:201<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:65<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.14<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.784<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.43<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CNV<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:147<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:42<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.644<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.7<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Drusen<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GG:54<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AG:23<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">AA:1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.16<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.689<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.25<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">Control</td><td valign="top" align="center" rowspan="1" colspan="1">GG:209</td><td valign="top" align="center" rowspan="1" colspan="1">AG:63</td><td valign="top" align="center" rowspan="1" colspan="1">AA:3</td><td valign="top" align="center" rowspan="1" colspan="1">0.13</td><td valign="top" align="center" rowspan="1" colspan="1">0.766</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec><title>Haplotype association analysis</title><p>We then performed haplotype analysis using Haploview 4.0, and 14, 15, and 14 haplotypes were observed in the AMD-control, wet AMD-control, and drusen-control groups, respectively. We found that haplotype TGTGCG and haplotype CGCGCG were shown to have a significant difference between both AMD-control (p=0.0064, p=0.006, respectively, <xref ref-type="table" rid="t4">Table 4</xref>) and wet AMD-control groups (p=0.0042, p=0.025, respectively, <xref ref-type="table" rid="t4">Table 4</xref>). The haplotype CGTGCG was shown to have a significant difference between both AMD-control (p=0.0102, <xref ref-type="table" rid="t4">Table 4</xref>) and drusen-control (p=0.032, <xref ref-type="table" rid="t4">Table 4</xref>). In addition, the haplotype CGTGTA was shown to have a significant difference between wet AMD and controls (p=0.026, <xref ref-type="table" rid="t4">Table 4</xref>). But none of the haplotypes were shown to have a significant difference between cases and controls (p&#x0003e;0.05, <xref ref-type="table" rid="t4">Table 4</xref>) after a stringent Bonferroni correction. On the other hand, the haplotype CGTGCA was shown to be significantly associated with soft drusen in our subject group (p=7.87x10<sup>&#x02212;5</sup>, <xref ref-type="table" rid="t4">Table 4</xref>) with frequencies of 0.11 in cases and 0.03 in controls, even after a stringent Bonferroni correction (p=0.0011, <xref ref-type="table" rid="t4">Table 4</xref>). This haplotype conferred a 3.72-fold (95% CI: 1.83&#x02013;7.54) increased likelihood of dry AMD (<xref ref-type="table" rid="t4">Table 4</xref>). Additionally, the haplotype CGTACA was also shown to have a significant difference between both all AMD-control and wet AMD-control groups (p&#x0003c;0.05, <xref ref-type="table" rid="t4">Table 4</xref>) after a stringent Bonferroni correction. However, the frequency of this haplotype was low and it was absent in the controls.</p><table-wrap id="t4" position="float"><label>Table 4</label><caption><title><italic>SERPING1</italic> haplotype association with AMD in the Han Chinese subject group.</title></caption><table frame="hsides" rules="groups"><col width="82" span="1"/><col width="84" span="1"/><col width="35" span="1"/><col width="55" span="1"/><col width="124" span="1"/><col width="74" span="1"/><col width="119" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Type of AMD</bold><hr/></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Haplotype</bold><hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Frequency</bold><hr/></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Haplotype association (p value)</bold><hr/></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Bufferoni correction</bold><hr/></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Odds ratio (95% CI)</bold><hr/></th></tr><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1">&#x000a0;</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">&#x000a0;</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Case</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Control</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>&#x000a0;</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>(p value)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">All AMD<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H1:CATGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0609<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H2:CGTGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.06<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1091<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H3:TGTGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.06<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0064<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0900<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H4:TGTACG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3301<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H5:CGTGCA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.2641<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H6:CGTGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.05<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0102<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1428<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H7:CATGTA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.4105<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H8:CATATG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.5689<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H9:TATGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3679<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H10:CGCGCA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.5900<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H11:CGTACA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0008<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0112<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H12:CGTACG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.4070<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H13:CGTGTA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0628<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H14:CGCGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0060<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0840<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Wet AMD<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H1:CATGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0717<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H2:CGTGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.06<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0946<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H3:TGTACG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.7668<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H4:TGTGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.06<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0042<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0630<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H5:CGTGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.05<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0620<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H6:CATGTA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.6366<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H7:CGTGCA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.5447<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H8:CATATG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.2741<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H9:CGCGCA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.5848<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H10:TATGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3616<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H11:CGTACG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.6028<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H12:CGCGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0256<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3840<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H13:CGTACA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0003<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0045<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H14:CATGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3513<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H15:CGTGTA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0263<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3950<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Drusen AMD<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H1:CATGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.62<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.2702<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H2:CGTGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.06<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.5894<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H3:CGTGCA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">7.87E-05<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.10E-03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.72 (1.83&#x02013;7.54)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H4:CGTGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.05<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0317<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.4438<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H5:TGTACG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0909<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H6:CATATG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.04<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.6489<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H7:TGTGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.05<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.1275<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H8:CATGTA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.03<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3929<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H9:CGTGTA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.6998<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H10:CGCGCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.00<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0894<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H11:TATGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.3297<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H12:CGCGCA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.8976<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">H13:CGTACG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.01<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.02<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.4630<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">H14:CATGCG</td><td valign="top" align="center" rowspan="1" colspan="1">0.00</td><td valign="top" align="center" rowspan="1" colspan="1">0.01</td><td valign="top" align="center" rowspan="1" colspan="1">0.2656</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Although genes in complement pathways, including <italic>CFH</italic>, <italic>C2/BF</italic>, and <italic>C3</italic> [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r8">8</xref>&#x02013;<xref ref-type="bibr" rid="r17">17</xref>] and chr.10q26 (<italic>LOC387715/HTRA1</italic>) [<xref ref-type="bibr" rid="r18">18</xref>&#x02013;<xref ref-type="bibr" rid="r24">24</xref>], have been identified as related to AMD, these loci could not explain all genetic contributions to AMD, suggesting that additional genetic variants related to AMD have not yet been found. Based on the candidate gene approach, Ennis et al. [<xref ref-type="bibr" rid="r25">25</xref>] reported that SNPs in <italic>SERPING1</italic> were significantly associated with AMD in two Caucasian populations. Additional evidence for <italic>SERPING1</italic> involving AMD includes: 1) <italic>SERPING1</italic> gene encoding C1INH plays an important role in complement pathways, which have been confirmed to participate in the pathogenesis of AMD; and 2) <italic>SERPING1</italic> was expressed in both retinal and RPE-choroid layers in RT&#x02013;PCR and immunofluorescence studies [<xref ref-type="bibr" rid="r25">25</xref>,<xref ref-type="bibr" rid="r29">29</xref>]. AMD affection status was correlated with increased abundance of choroidal C1INH [<xref ref-type="bibr" rid="r29">29</xref>]. Complement activation pathways include lectin, classical and alternative pathways. <italic>SERPING1</italic> encodes C1INH, an inhibitor of the classical and lectin pathways of complement activation. The classical complement pathway is initiated by the C1 complex, which comprises a C1q hexamer complex with a zymogenic (C1r)<sub>2</sub>-(C1s) <sub>2</sub>). SERPING1 irreversibly inhibits C1r and C1s, MASP-1 (mannan-binding lectin serine peptidase 1), and MASP-2 (mannan-binding lectin serine peptidase 2, the C1s ortholog in the lectin pathway), as well as modulating the complement activation through inhibition unrelated to proteases [<xref ref-type="bibr" rid="r30">30</xref>&#x02013;<xref ref-type="bibr" rid="r33">33</xref>]. However, Park et al. [<xref ref-type="bibr" rid="r26">26</xref>] were unable to replicate the association between the genetic variation in <italic>SERPING1</italic> and AMD in two large and well characterized Caucasian subject groups, and Allikmets et al. [<xref ref-type="bibr" rid="r34">34</xref>] were also unable to replicate the association between <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs2511989">rs2511989</ext-link> in <italic>SERPING1</italic> and AMD. Additional replication studies, especially of a different ethnicity, are important to determine if <italic>SERPING1</italic> is really associated with AMD. None of the six SNPs showed significant association with AMD and none of the major haplotypes were observed to be significantly associated with AMD or choroid neovascularization AMD (CNV) after a stringent Bonferroni correction in our study, suggesting that <italic>SERPING1</italic> may not be related to AMD in the Han Chinese population. In the haplotype analysis, none of the SNPs tagged the significant haplotypes. Because half of samples&#x02019; genotype data for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs11546660">rs11546660</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp?term=rs4926">rs4926</ext-link> was not available in the HapMap3 for the Chinese, we cannot compare the haplotype frequencies to those in the HapMap. Although four haplotypes including TGTGCG, CGCGCG, CGTGCG, and CGTGTA were shown to have significant associations with different subphenotypes of AMD, anymore after a stringent Bonferroni correction, the significant associations no longer existed, suggesting that these haplotypes were not specifically associated with AMD. Since the haplotype CGTACA was rare in all AMD (3%) and wet groups (3%), and absent in the drusen group and controls, we think that the significant association between this haplotype and AMD is not reliable. The haplotype CGTGCA was shown to be significantly associated with soft drusen in the subject group even after a stringent Bonferroni correction (p=0.0011, <xref ref-type="table" rid="t4">Table 4</xref>). Further replication studies are needed to clarify the current situation because of the limited number of soft drusen samples in this study.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank the participating AMD patients and their families. The authors acknowledge the following grant support (to Z. Yang): Department of Science and Technology of Sichuan Province (04JY029&#x02013;045, 05ZQ026&#x02013;018); Natural Science Foundation of China (30671182, 30771220).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>PT</given-names></name></person-group><article-title>Age-related macular degeneration.</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><fpage>1474</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">17021323</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>RJ</given-names></name><name><surname>Zeiss</surname><given-names>C</given-names></name><name><surname>Chew</surname><given-names>EY</given-names></name><name><surname>Tsai</surname><given-names>JY</given-names></name><name><surname>Sackler</surname><given-names>RS</given-names></name><name><surname>Haynes</surname><given-names>C</given-names></name><name><surname>Henning</surname><given-names>AK</given-names></name><name><surname>SanGiovanni</surname><given-names>JP</given-names></name><name><surname>Mane</surname><given-names>SM</given-names></name><name><surname>Mayne</surname><given-names>ST</given-names></name><name><surname>Bracken</surname><given-names>MB</given-names></name><name><surname>Ferris</surname><given-names>FL</given-names></name><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Barnstable</surname><given-names>C</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name></person-group><article-title>Complement factor H polymorphism in age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>385</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15761122</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaroop</surname><given-names>A</given-names></name><name><surname>Branham</surname><given-names>KE</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name></person-group><article-title>Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits.</article-title><source>Hum Mol Genet</source><year>2007</year><volume>16</volume><fpage>R174</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">17911160</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddad</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>CA</given-names></name><name><surname>Santangelo</surname><given-names>SL</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>The genetics of age-related macular degeneration: a review of progress to date.</article-title><source>Surv Ophthalmol</source><year>2006</year><volume>51</volume><fpage>316</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">16818082</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>JM</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name><name><surname>Klein</surname><given-names>ML</given-names></name></person-group><article-title>CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration.</article-title><source>Hum Hered</source><year>2006</year><volume>61</volume><fpage>157</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">16816528</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>PJ</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Schultz</surname><given-names>DW</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name><name><surname>Hamon</surname><given-names>S</given-names></name><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Weleber</surname><given-names>RG</given-names></name><name><surname>Klein</surname><given-names>ML</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration.</article-title><source>Hum Hered</source><year>2007</year><volume>63</volume><fpage>212</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17347568</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>JM</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name></person-group><article-title>Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration.</article-title><source>Arch Ophthalmol</source><year>2006</year><volume>124</volume><fpage>995</fpage><lpage>1001</lpage><pub-id pub-id-type="pmid">16832023</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zareparsi</surname><given-names>S</given-names></name><name><surname>Branham</surname><given-names>KE</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Klein</surname><given-names>RJ</given-names></name><name><surname>Ott</surname><given-names>J</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Swaroop</surname><given-names>A</given-names></name></person-group><article-title>Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration.</article-title><source>Am J Hum Genet</source><year>2005</year><volume>77</volume><fpage>149</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15895326</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Olson</surname><given-names>LM</given-names></name><name><surname>Gallins</surname><given-names>P</given-names></name><name><surname>Spencer</surname><given-names>KL</given-names></name><name><surname>Kwan</surname><given-names>SY</given-names></name><name><surname>Noureddine</surname><given-names>M</given-names></name><name><surname>Gilbert</surname><given-names>JR</given-names></name><name><surname>Schnetz-Boutaud</surname><given-names>N</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Postel</surname><given-names>EA</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name></person-group><article-title>Complement factor H variant increases the risk of age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>419</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15761120</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hageman</surname><given-names>GS</given-names></name><name><surname>Anderson</surname><given-names>DH</given-names></name><name><surname>Johnson</surname><given-names>LV</given-names></name><name><surname>Hancox</surname><given-names>LS</given-names></name><name><surname>Taiber</surname><given-names>AJ</given-names></name><name><surname>Hardisty</surname><given-names>LI</given-names></name><name><surname>Hageman</surname><given-names>JL</given-names></name><name><surname>Stockman</surname><given-names>HA</given-names></name><name><surname>Borchardt</surname><given-names>JD</given-names></name><name><surname>Gehrs</surname><given-names>KM</given-names></name><name><surname>Smith</surname><given-names>RJ</given-names></name><name><surname>Silvestri</surname><given-names>G</given-names></name><name><surname>Russell</surname><given-names>SR</given-names></name><name><surname>Klaver</surname><given-names>CC</given-names></name><name><surname>Barbazetto</surname><given-names>I</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Yannuzzi</surname><given-names>LA</given-names></name><name><surname>Barile</surname><given-names>GR</given-names></name><name><surname>Merriam</surname><given-names>JC</given-names></name><name><surname>Smith</surname><given-names>RT</given-names></name><name><surname>Olsh</surname><given-names>AK</given-names></name><name><surname>Bergeron</surname><given-names>J</given-names></name><name><surname>Zernant</surname><given-names>J</given-names></name><name><surname>Merriam</surname><given-names>JE</given-names></name><name><surname>Gold</surname><given-names>B</given-names></name><name><surname>Dean</surname><given-names>M</given-names></name><name><surname>Allikmets</surname><given-names>R</given-names></name></person-group><article-title>A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>7227</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">15870199</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AO</given-names></name><name><surname>Ritter</surname><given-names>R</given-names><suffix>3rd</suffix></name><name><surname>Abel</surname><given-names>KJ</given-names></name><name><surname>Manning</surname><given-names>A</given-names></name><name><surname>Panhuysen</surname><given-names>C</given-names></name><name><surname>Farrer</surname><given-names>LA</given-names></name></person-group><article-title>Complement factor H polymorphism and age-related macular degeneration.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>421</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15761121</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Atmaca-Sonmez</surname><given-names>P</given-names></name><name><surname>Othman</surname><given-names>M</given-names></name><name><surname>Branham</surname><given-names>KE</given-names></name><name><surname>Khanna</surname><given-names>R</given-names></name><name><surname>Wade</surname><given-names>MS</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Zareparsi</surname><given-names>S</given-names></name><name><surname>Swaroop</surname><given-names>A</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name></person-group><article-title>CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration.</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>1049</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">16936733</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Fagerness</surname><given-names>J</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration.</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>1055</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16936732</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>B</given-names></name><name><surname>Merriam</surname><given-names>JE</given-names></name><name><surname>Zernant</surname><given-names>J</given-names></name><name><surname>Hancox</surname><given-names>LS</given-names></name><name><surname>Taiber</surname><given-names>AJ</given-names></name><name><surname>Gehrs</surname><given-names>K</given-names></name><name><surname>Cramer</surname><given-names>K</given-names></name><name><surname>Neel</surname><given-names>J</given-names></name><name><surname>Bergeron</surname><given-names>J</given-names></name><name><surname>Barile</surname><given-names>GR</given-names></name><name><surname>Smith</surname><given-names>RT</given-names></name></person-group><article-title>AMD Genetics Clinical Study Group, Hageman GS, Dean M, Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>458</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">16518403</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yates</surname><given-names>JR</given-names></name><name><surname>Sepp</surname><given-names>T</given-names></name><name><surname>Matharu</surname><given-names>BK</given-names></name><name><surname>Khan</surname><given-names>JC</given-names></name><name><surname>Thurlby</surname><given-names>DA</given-names></name><name><surname>Shahid</surname><given-names>H</given-names></name><name><surname>Clayton</surname><given-names>DG</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Morgan</surname><given-names>J</given-names></name><name><surname>Wright</surname><given-names>AF</given-names></name><name><surname>Armbrecht</surname><given-names>AM</given-names></name><name><surname>Dhillon</surname><given-names>B</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><name><surname>Redmond</surname><given-names>E</given-names></name><name><surname>Bird</surname><given-names>AC</given-names></name><name><surname>Moore</surname><given-names>AT</given-names></name><collab>Genetic Factors in AMD Study Group.</collab></person-group><article-title>Complement C3 variant and the risk of age-related macular degeneration.</article-title><source>N Engl J Med</source><year>2007</year><volume>357</volume><fpage>553</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17634448</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maller</surname><given-names>JB</given-names></name><name><surname>Fagerness</surname><given-names>JA</given-names></name><name><surname>Reynolds</surname><given-names>RC</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Seddon</surname><given-names>JM</given-names></name></person-group><article-title>Variation in complement factor 3 is associated with risk of age-related macular degeneration.</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>1200</fpage><lpage>1</lpage><pub-id pub-id-type="pmid">17767156</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>KL</given-names></name><name><surname>Hauser</surname><given-names>MA</given-names></name><name><surname>Olson</surname><given-names>LM</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Gallins</surname><given-names>P</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Postel</surname><given-names>EA</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name></person-group><article-title>Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.</article-title><source>Hum Mol Genet</source><year>2008</year><volume>17</volume><fpage>971</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18084039</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewan</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Hartman</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>SS</given-names></name><name><surname>Liu</surname><given-names>DT</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Tam</surname><given-names>PO</given-names></name><name><surname>Chan</surname><given-names>WM</given-names></name><name><surname>Lam</surname><given-names>DS</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name><name><surname>Barnstable</surname><given-names>C</given-names></name><name><surname>Pang</surname><given-names>CP</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name></person-group><article-title>HTRA1 promoter polymorphism in wet age-related macular degeneration.</article-title><source>Science</source><year>2006</year><volume>314</volume><fpage>989</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">17053108</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>F</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Liao</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>Q</given-names></name><name><surname>Lei</surname><given-names>C</given-names></name><name><surname>Cameron</surname><given-names>DJ</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><article-title>HTRA1 variant increases risk to neovascular age-related macular degeneration in Chinese population.</article-title><source>Vision Res</source><year>2007</year><volume>47</volume><fpage>3120</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">17904186</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>JM</given-names></name><name><surname>Wan</surname><given-names>L</given-names></name><name><surname>Tsai</surname><given-names>YY</given-names></name><name><surname>Lin</surname><given-names>HJ</given-names></name><name><surname>Tsai</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>CC</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Tseng</surname><given-names>SH</given-names></name></person-group><article-title>HTRA1 polymorphism in dry and wet age-related macular degeneration.</article-title><source>Retina</source><year>2008</year><volume>28</volume><fpage>309</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">18301036</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>PO</given-names></name><name><surname>Ng</surname><given-names>TK</given-names></name><name><surname>Liu</surname><given-names>DT</given-names></name><name><surname>Chan</surname><given-names>WM</given-names></name><name><surname>Chiang</surname><given-names>SW</given-names></name><name><surname>Chen</surname><given-names>LJ</given-names></name><name><surname>DeWan</surname><given-names>A</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name><name><surname>Lam</surname><given-names>DS</given-names></name><name><surname>Pang</surname><given-names>CP</given-names></name></person-group><article-title>HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>2357</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">18316707</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>DeWan</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Sakamoto</surname><given-names>R</given-names></name><name><surname>Okamoto</surname><given-names>H</given-names></name><name><surname>Minami</surname><given-names>M</given-names></name><name><surname>Obazawa</surname><given-names>M</given-names></name><name><surname>Mizota</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Takagi</surname><given-names>I</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name></person-group><article-title>HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>545</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17438519</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Ishibashi</surname><given-names>K</given-names></name><name><surname>Tsukahara</surname><given-names>Y</given-names></name><name><surname>Negi</surname><given-names>A</given-names></name></person-group><article-title>LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population.</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>608</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">17692272</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Camp</surname><given-names>NJ</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name><name><surname>Gibbs</surname><given-names>D</given-names></name><name><surname>Cameron</surname><given-names>DJ</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Pearson</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Chien</surname><given-names>J</given-names></name><name><surname>Dewan</surname><given-names>A</given-names></name><name><surname>Harmon</surname><given-names>J</given-names></name><name><surname>Bernstein</surname><given-names>PS</given-names></name><name><surname>Shridhar</surname><given-names>V</given-names></name><name><surname>Zabriskie</surname><given-names>NA</given-names></name><name><surname>Hoh</surname><given-names>J</given-names></name><name><surname>Howes</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name></person-group><article-title>A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.</article-title><source>Science</source><year>2006</year><volume>314</volume><fpage>992</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">17053109</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ennis</surname><given-names>S</given-names></name><name><surname>Jomary</surname><given-names>C</given-names></name><name><surname>Mullins</surname><given-names>R</given-names></name><name><surname>Cree</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Macleod</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Collins</surname><given-names>A</given-names></name><name><surname>Stone</surname><given-names>E</given-names></name><name><surname>Lotery</surname><given-names>A</given-names></name></person-group><article-title>Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.</article-title><source>Lancet</source><year>2008</year><volume>372</volume><fpage>1828</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">18842294</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>KH</given-names></name><name><surname>Ryu</surname><given-names>E</given-names></name><name><surname>Tosakulwong</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Edwards</surname><given-names>AO</given-names></name></person-group><article-title>Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects.</article-title><source>Mol Vis</source><year>2009</year><volume>15</volume><fpage>200</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19169411</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname><given-names>AC</given-names></name><name><surname>Bressler</surname><given-names>NM</given-names></name><name><surname>Bressler</surname><given-names>SB</given-names></name><name><surname>Chisholm</surname><given-names>IH</given-names></name><name><surname>Coscas</surname><given-names>G</given-names></name><name><surname>Davis</surname><given-names>MD</given-names></name><name><surname>de Jong</surname><given-names>PTVM</given-names></name><name><surname>Klaver</surname><given-names>CCW</given-names></name><name><surname>Klein</surname><given-names>BEK</given-names></name><name><surname>Klein</surname><given-names>R</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Sarks</surname><given-names>JP</given-names></name><name><surname>Sarks</surname><given-names>SH</given-names></name><name><surname>Soubrane</surname><given-names>G</given-names></name><name><surname>Taylor</surname><given-names>HR</given-names></name><name><surname>Vingerling</surname><given-names>JR</given-names></name></person-group><article-title>An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.</article-title><source>Surv Ophthalmol</source><year>1995</year><volume>39</volume><fpage>367</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">7604360</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>The International HapMap Consortium</collab><collab>The International HapMap Project</collab></person-group><source>Nature</source><year>2003</year><volume>426</volume><fpage>789</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">14685227</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>RF</given-names></name><name><surname>Faidley</surname><given-names>EA</given-names></name><name><surname>Daggett</surname><given-names>HT</given-names></name><name><surname>Jomary</surname><given-names>C</given-names></name><name><surname>Lotery</surname><given-names>AJ</given-names></name><name><surname>Stone</surname><given-names>EM</given-names></name></person-group><article-title>Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration.</article-title><source>Exp Eye Res</source><year>2009</year><volume>89</volume><fpage>767</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">19607829</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziccardi</surname><given-names>RJ</given-names></name><name><surname>Cooper</surname><given-names>NR</given-names></name></person-group><article-title>Activation of C1r by proteolytic cleavage.</article-title><source>J Immunol</source><year>1976</year><volume>116</volume><fpage>504</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1249422</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arlaud</surname><given-names>GJ</given-names></name><name><surname>Reboul</surname><given-names>A</given-names></name><name><surname>Sim</surname><given-names>RB</given-names></name><name><surname>Colomb</surname><given-names>MG</given-names></name></person-group><article-title>Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.</article-title><source>Biochim Biophys Acta</source><year>1979</year><volume>576</volume><fpage>151</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">760802</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>FK</given-names></name><name><surname>Thomas</surname><given-names>AR</given-names></name><name><surname>Wijeyewickrema</surname><given-names>LC</given-names></name><name><surname>Whisstock</surname><given-names>JC</given-names></name><name><surname>Boyd</surname><given-names>SE</given-names></name><name><surname>Kaiserman</surname><given-names>D</given-names></name><name><surname>Matthews</surname><given-names>AY</given-names></name><name><surname>Bird</surname><given-names>PI</given-names></name><name><surname>Thielens</surname><given-names>NM</given-names></name><name><surname>Rossi</surname><given-names>V</given-names></name><name><surname>Pike</surname><given-names>RN</given-names></name></person-group><article-title>Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.</article-title><source>Mol Immunol</source><year>2008</year><volume>45</volume><fpage>670</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17709141</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray-Rust</surname><given-names>TA</given-names></name><name><surname>Kerr</surname><given-names>FK</given-names></name><name><surname>Thomas</surname><given-names>AR</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Yongqing</surname><given-names>T</given-names></name><name><surname>Ong</surname><given-names>PC</given-names></name><name><surname>Quinsey</surname><given-names>NS</given-names></name><name><surname>Whisstock</surname><given-names>JC</given-names></name><name><surname>Wagenaar-Bos</surname><given-names>IC</given-names></name><name><surname>Freeman</surname><given-names>C</given-names></name><name><surname>Pike</surname><given-names>RN</given-names></name></person-group><article-title>Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1.</article-title><source>Biochem J</source><year>2009</year><volume>422</volume><fpage>295</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">19522701</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allikmets</surname><given-names>R</given-names></name><name><surname>Dean</surname><given-names>M</given-names></name><name><surname>Hageman</surname><given-names>GS</given-names></name><name><surname>Baird</surname><given-names>PN</given-names></name><name><surname>Klaver</surname><given-names>CC</given-names></name><name><surname>Bergen</surname><given-names>AA</given-names></name><name><surname>Weber</surname><given-names>BH</given-names></name><collab>International AMD Genetics Consortium.</collab></person-group><article-title>The SERPING1 gene and age-related macular degeneration.</article-title><source>Lancet</source><year>2009</year><volume>374</volume><fpage>875</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19748388</pub-id></mixed-citation></ref></ref-list></back></article>